CURE Logo.png
CURE Pharmaceutical to Present at Two Virtual Events in September
September 02, 2020 08:30 ET | CURE Pharmaceutical Holding Corp.
- CURE will present at the LD 500 Virtual Conference, September 4 at 8:20 am PDT -  - CURE CEO will be a panelist at the 4@4 Forum on September 10 @4pm PDT - OXNARD, Calif., Sept. 02, 2020 (GLOBE...
CURE Logo.png
CURE Pharmaceutical to Acquire Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, in a $20 Million Transaction
July 28, 2020 08:00 ET | CURE Pharmaceutical Holding Corp.
MOU to acquire 100% of privately held Sera Labs for $20 million, which consists primarily of stock with key earn out considerations totaling up to an additional $20 million within two years of...
CURE Logo.png
CURE Pharmaceutical CBD Oral Thin Film Pharmacokinetic Study Shows Improved Bioavailability Compared to CBD Soft Gel
July 15, 2020 08:00 ET | CURE Pharmaceutical Holding Corp.
OXNARD, Calif., July 15, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that its 25mg cannabidiol (CBD) oral thin film...
CURE Logo.png
CURE Pharmaceutical Receives NSF’s cGMP Certification for Dietary Supplements
July 08, 2020 08:00 ET | CURE Pharmaceutical Holding Corp.
OXNARD, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical, (OTC: CURR), an innovative drug delivery and development company, today announced that its 25,000 square foot manufacturing...
CURE Pharmaceutical Appoints Chief Business Officer
June 16, 2020 08:00 ET | CURE Pharmaceutical Holding Corp.
OXNARD, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical, (OTC: CURR), an innovative drug delivery and development company, today named Jonathan Berlent, 51, to the newly created...
CURE Logo.png
CURE Pharmaceutical Announces Exercise of Warrants for Cash Proceeds of Approximately $1.4 Million and Completes Earn Out Related to 2019 Acquisition
June 09, 2020 11:22 ET | CURE Pharmaceutical Holding Corp.
OXNARD, Calif., June 09, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical Holding Corp. (OTC: CURR), an innovative drug delivery company that is developing novel ways to deliver active ingredients,...
CURE Logo.png
CURE Pharmaceutical [OTCQB:CURR] Expands to Mexico in Collaboration with Factoria Bogar Subsidiary
June 03, 2020 07:15 ET | Cure Pharmaceutical Holding Corp.
OXNARD, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, announced today a collaboration with PMI, a subsidiary of...
CURE Logo.png
CURE Pharmaceutical [OTCQB:CURR] Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions
April 21, 2020 07:30 ET | Cure Pharmaceutical Holding Corp.
LOS ANGELES, April 21, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the issuance of two U.S. Patents: No. 10,639,339...
CURE Logo.png
CURE Pharmaceutical [OTCQB:CURR] Secures Chinese Patent on its Oral Thin Films to Treat Erectile Dysfunction
March 17, 2020 08:30 ET | Cure Pharmaceutical Holding Corp.
OXNARD, Calif., March 17, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of Chinese Patent No....
CURE Logo.png
CURE Pharmaceutical [OTCQB:CURR] Licenses Cannabis Extraction Patents to Vanguard Scientific
February 12, 2020 07:15 ET | Cure Pharmaceutical Holding Corp.
LOS ANGELES, Feb. 12, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced a licensing and collaboration agreement with...